Screener
Neuropace, Inc. NPCE Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:33 PM EDT
- Fiscal quarter
- Q4 FY2030
- Calendar quarter
- Q4 2030
- Accession
- 0001528287-26-000030
FAQ
- What is Neuropace, Inc.'s accrued expenses?
- Neuropace, Inc. (NPCE) reported accrued expenses of $8.07M in Q2 2026.
- How has Neuropace, Inc.'s accrued expenses changed year-over-year?
- Neuropace, Inc.'s accrued expenses increased by 14.0% year-over-year, from $7.08M to $8.07M.
- What is the long-term trend for Neuropace, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s accrued expenses has grown at a 17.8% compound annual growth rate (CAGR), from $4.57M to $10.34M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Neuropace, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude